Yotaro Motomura, Tomoyuki Arimatsu, Keigo Okada, Takashi Kumagai (Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan)
Session information
Oral Session
Oral Session 1-10B MTX-associated LPD
Fri. Oct 11, 2019 10:10 AM - 11:10 AM No.10 (Tokyo International Forum, 4F G409)
Chair: Hisashi Tsurumi (Department of Hematology, Matsunami General Hospital)
Takuya Harada1, Koji Kato1, Kentaro Kohno2, Ken Takase2, Goichi Yoshimoto1, Masanori Kadowaki2, Satoshi Yamasaki2, Kohta Miyawaki1, Takeshi Sugio1, Kensuke Sasaki1, Yasuo Mori1, Akihiko Numata1, Takahiro Maeda1, Toshihiro Miyamoto1, Hiromi Iwasaki2, Koichi Akashi1 (1.Department of Medicine and Biosystemic Science, Kyusyu University, 2.Department of Hematology, National Hospital Organization Kyushu Medical Center)
Takahiro Arano, Hirotaka Nakahashi, Shigeki Kosugi, Yoshitora Kin, Tomoyuki Izumi (Department of Hematology, Fukaya Red Cross Hospital, Saitama, Japan)
Yoshihiko Hoshida1, Shiro Ohshima2, Yukihiko Saeki2, Masao Katayama3, Tomoya Miyamura4, Atsushi Hashimoto5, Toshihiko Murayama6, Shinji Higa7, Hisaji Oshima8, Yasushi Hiramatsu9, Kazuya Kuraoka10, Tomoaki Fujisaki11, Norie Yoshikawa12, Akiko Mitsuo13, Atsuhiro Kawashima14, Akira Okamoto15, Noriyuki Chiba16, Kennichi Taguchi17, Mitsutoshi Kurosawa18, Masato Yagita19, Hiroyuki Sugahara20, Norihiro Teramoto21, Takao Sugiyama22, Yoshihiro Yoshihara23, Kyogo Setoguchi24, Atsushi Ibata25, Yoko Shinno26, Syohei Nagaoka27, Hiroki Yabe28, Shigeto Tohma29 (1.Pathol., Osaka Minami Medical Center, Kawachinagano, Japan, 2.Rheumatol., Osaka Minami Medical Center, Kawachinagano, Japan, 3.Rheumatol., Nagoya Medical Center, Nagoya, Japan, 4.Rheumatol., Kyusyu Medical Center, Fukuoka, Japan, 5.Rheumatol., Sagamihara Hospital, Sagamihara, Japan, 6.Pathol., Kumamoto Medical Center, Kumamoto, Japan, 7.Rheumatol., Second Osaka Police Hospital, Osaka, Japan, 8.Rheumatol., Tokyo Medical Center, Tokyo, Japan, 9.Hematol. Oncology, Japanease Red Cross Society Himeji Hospital, Himeji, Japan, 10.Pathol., Kure Med. Ctr./Chugoku Cancer Ctr., Kure, Japan, 11.Hematol., Matsuyama Red Cross Hospital, Matsuyama, Japan, 12.Rheumatol., Miyakonojyo Medical Center, Miyakonojyo, Japan, 13.Rheumatol., Disaster Medical Center, Tachikawa, Japan, 14.Pathol., Kanazawa Medical Center, Kanazawa, Japan, 15.Rheumatol., Himeji Medical Center, Himeji, Japan, 16.Rheumatol., Morioka Medical Center, Morioka, Japan, 17.Pathol., Kyusyu Cancer Center, Fukuoka, Japan, 18.Hematol., Hokkaido Cancer Center, Sapporo, Japan, 19.Rheumatol., Kitano Hospital, Osaka, Japan, 20.Hematol., Sumitomo Hospital, Osaka, Japan, 21.Pathol., Sikoku Cancer Center, Matsuyama, Japan, 22.Rheumatol., Shimoshizu Hospital, Shimoshizu, Japan, 23.Rheumatol., Hyogo Prefecture Kakogawa Hospital, Kakogawa, Japan, 24.Rheumatol., Tokyo Metropolitan Cancer and Infectious Didease, Tokyo, Japan, 25.Rheumatol., Yokohama Medical Center, Yokohama, Japan, 26.Pathol., Okayama Medical Center, Okayama, Japan, 27.Rheumatol., Yokohama Minami Kyousai Hospital, Yokohama, Japan, 28.Hematol., Ako Central Hospital, Ako, Japan, 29.Rheumatol., Tokyo Hospital, Tokyo, Japan)
Takayuki Sakuma1, Rika Sakai1, Ayumi Numata1, Kenji Motohashi1, Hirotaka Takasaki1, Kota Washimi2, Tomoyuki Yokose2, Hideaki Nakajima3 (1.Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan, 2.Pathology, Kanagawa Cancer Center, Yokohama, Japan, 3.Hematology and Clinical Immunology, Yokohama City University, Yokohama, Japan)
Seiji Kakiuchi1, Ikumi Takagi1, Junpei Rikitake1, Naoko Nanbu2, Kazuhiro Teramura2, Yoshitake Hayashi3, Nobuko Iwata1 (1.Dept. Hematology, Yodogawa Christian Hospital, Osaka, Japan, 2.Dept. Pathology, Yodogawa Christian Hospital, Osaka, Japan, 3.Dept. Pathology, Mol. Med. Med. Genet., Kobe Univ., Kobe, Japan)